Domača stran540222 • BOM
add
Laurus Labs Ltd
Prejšnji trg. dan.
556,90 ₹
Dnevni razpon
553,95 ₹ - 568,95 ₹
Letni razpon
358,70 ₹ - 619,50 ₹
Tržna kapitalizacija
300,81 mrd. INR
Povprečni obseg
71,12 tis.
Razm. P/E
229,30
Dividendna donosnost
0,14 %
Primarna borza
NSE
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (INR) | sep. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 12,24 mrd. | −0,06 % |
Stroški poslovanja | 6,05 mrd. | 10,51 % |
Čisti dohodek | 198,40 mio. | −46,31 % |
Čista dobičkovnost prihodkov | 1,62 | −46,36 % |
Earnings per share | 0,37 | −45,59 % |
EBITDA | 1,78 mrd. | −5,65 % |
Efektivna davčna stopnja | 20,33 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (INR) | sep. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 449,20 mio. | −33,11 % |
Skupna sredstva | 87,29 mrd. | 8,34 % |
Skupne obveznosti | 45,85 mrd. | 14,21 % |
Celoten lastniški kapital | 41,44 mrd. | — |
Shares outstanding | 536,22 mio. | — |
Razmerje P/B | 7,22 | — |
Donosnost sredstev | — | — |
Donosnost kapitala | 2,60 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (INR) | sep. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 198,40 mio. | −46,31 % |
Denar iz dejavnosti | — | — |
Denar iz naložb | — | — |
Denar iz financiranja | — | — |
Neto sprememba denarnih sredstev | — | — |
Prost denarni tok | — | — |
Vizitka
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
Generalni direktor
Datum ustanovitve
2005
Spletno mesto
Zaposleni
6.007
